Antibacterial activity of long-chain fatty alcohols against mycobacteria

FEMS Microbiology Letters

Volumn 338, Issue 2, 2013, Pages 177-183

  Mukherjee, Koushik ^a   Tribedi, Prosun ^a   Mukhopadhyay, Balaram ^b   Sil, Alok Kumar ^a  

^a UNIVERSITY OF CALCUTTA   (India)

^b INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH KOLKATA   (India)

Author keywords

Biofilm; Long chain fatty alcohol; Mycobacteria

Indexed keywords

5 HEXENE 1 OL; 9 DECENE 1 OL; ALKANOL; DECANOL; FATTY ALCOHOL; HEPTANOL; HEXANOL; HEXENE 1 OL; LAURYL ALCOHOL; NONANOL; OCTANOL; TRIDECANOL; UNCLASSIFIED DRUG; UNDECANOL;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; BIOFILM; CONTROLLED STUDY; DRUG STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BIOFILMS; FATTY ALCOHOLS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; STRUCTURE-ACTIVITY RELATIONSHIP;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 84871721863     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/1574-6968.12043     Document Type: Article

References (29)

1. Adams LB, Sinha I, Franzblau SG, Krahenbuhl JL & Mehta RT (1999) Effective treatment of acute and chronic murine tuberculosis with liposome-encapsulated clofazimine. Antimicrob Agents Chemother 43: 1638-1643.
2. Andries K, Verhasselt P, Guillemont J et al. (2005) A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307: 223-227.
3. Bauer AW, Kirby WMM, Sherris JC & Turk M (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45: 493-496.
4. Charles C (1974) Current Techniques for Antibiotic Susceptibility Testing. Thomas Publisher, Springfield, IL.
5. De Bont Jan AM (1998) Solvent-tolerant bacteria in biocatalysis. Trends Biotechnol 16: 493-499.
6. Falkinham JO III, Macri RV, Maisuria BB et al. (2012) Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria. Tuberculosis 92: 173-181.
7. Hurdle JG, O'Neill AJ, Chopra I & Lee RE (2011) Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat Rev Microbiol 9: 62-75.
8. Ingram LO (1976) Adaptation of membrane lipids to alcohols. J Bacteriol 125: 670-678.
9. Jarlier V & Nikaido H (1994) Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett 123: 11-18.
10. Júnior CO, le Hyaric M, Costa CF, Corrêa TA, Taveira AF, Araújo DP, Reis EF, Lourenço MC, Vicente FR & Almeida MV (2009) Preparation and antitubercular activity of lipophilic diamines and amino alcohols. Mem Inst Oswaldo Cruz 104: 703-705.
11. Kabelitz N, Santos PM & Heipieper HJ (2003) Effect of aliphatic alcohols on growth and degree of saturation of membrane lipids in Acinetobacter calcoaceticus. FEMS Microbiol Lett 220: 223-227.
12. Kakwani MD, Suryavanshi P, Ray M, Rajan MG, Majee S, Samad A, Devarajan P & Degani MS (2011) Design, synthesis and antimycobacterial activity of cinnamide derivatives: a molecular hybridization approach. Bioorg Med Chem Lett 21: 1997-1999.
13. Kato N & Shibasaki I (1980) The antimicrobial characteristics of 1-alkanols. J Antibact Antifung Agents 8: 325-331.
14. Kato N, Yanagida S, Okahara M & Shibasaki I (1978) Antibacterial activity of alcohols and oxyethylated alcohols. J Antibact Antifung Agents 6: 527-531.
15. Koul A, Vranckx L Dendouga N et al. (2008) Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. J Biol Chem 283: 25273-25280.
16. Koyama N, Kojima S, Nonaka K, Masuma R, Matsumoto M, Omura S & Tomoda H (2010) Calpinactam, a new anti-mycobacterial agent, produced by Mortierella alpina FKI-4905. J Antibiot 63: 183-186.
17. Kubo I, Muroi H, Himejima H & Kubo A (1993a) Antibacterial activity of long-chain alcohols: the role of hydrophobic alkyl groups. Bioorg Med Chem Lett 3: 1305-1308.
18. Kubo I, Muroi H & Kubo A (1993b) Antibacterial activity of long-chain alcohol against Streptococcus mutans. J Agric Food Chem 41: 2447-2450.
19. Lansford EM Jr, Hill ID & Shive W (1960) Reversal by ribonucleosides of bacterial growth inhibition caused by alcohol. J Biol Chem 235: 3551-3555.
20. Lougheed KE, Taylor DL, Osborne SA, Bryans JS & Buxton RS (2011) New anti-tuberculosis agents amongst known drugs. Tuberculosis 89: 364-370.
21. Mates A (1974) The effect of alcohols on growth and lipase formation by Staphylococcus aureus. J Appl Bacteriol 37: 1-6.
22. Parsek M & Singh PK (2003) Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 57: 677-701.
23. Pogliano J, Pogliano N & Silverman J (2012) Daptomycin mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins. J Bacteriol 194: 4494-4504.
24. Ravel JM, Felsing B, Lansford EM Jr, Trubey RH & Shive W (1955) Reversal of alcohol toxicity by glutamine. J Biol Chem 214: 497-501.
25. Rugutt JK & Rugutt KJ (2011) Antimycobacterial activity of steroids, long-chain alcohols and lytic peptides. Nat Prod Res 26: 1004-1011.
26. Sheu CW & Freese E (1973) Lipopolysaccharide layer protection of Gram-negative bacteria against inhibition by long-chain fatty acids. J Bacteriol 115: 869-875.
27. Sikkema J, de Bont JA & Poolman B (1995) Mechanisms of membrane toxicity of hydrocarbons. Microbiol Rev 59: 201-222.
28. Tanaka Y, Fukuda S, Kikuzaki H & Nakatani N (2002) Antibacterial activity of aliphatic long-chain compounds against upper-airway respiratory tract bacteria. ITE Lett Batter New Technol Med 1: 777-780.
29. Togashi N, Shiraishi A, Nishizaka M, Matsuoka K, Endo K, Hamashima H & Inoue Y (2007) Antibacterial activity of long-chain fatty alcohols against Staphylococcus aureus. Molecules 12: 139-148.